Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide

[1]  H. Müller,et al.  Effects of leflunomide (HWA 486) on expression of lymphocyte activation markers , 2005, Agents and Actions.

[2]  R. Schleyerbach,et al.  Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection , 2005, Agents and Actions.

[3]  R. Schleyerbach,et al.  Effects of leflunomide on immune responses and models of inflammation , 2004, Springer Seminars in Immunopathology.

[4]  A. Chong,et al.  Immunosuppressive effects of leflunomide in a cardiac allograft model. , 1993, Transplantation proceedings.

[5]  F. Seiler,et al.  Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative. , 1993, Transplantation proceedings.

[6]  T. Starzl,et al.  GRAFT‐VERSUS‐HOST DISEASE AFTER BROWN NORWAY‐TO‐LEWIS AND LEWIS‐TO‐BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK506 , 1993, Transplantation.

[7]  A. Monaco,et al.  Prevention of graft-versus-host disease by RS-61443 in two different rodent models. , 1993, Transplantation.

[8]  W. Müller‐ruchholtz,et al.  Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide. , 1992, Transplantation proceedings.

[9]  K. H. Langer,et al.  Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. , 1991, Transplantation proceedings.

[10]  K. H. Langer,et al.  Leflunomide (HWA 486) inhibits experimental autoimmune tubulointerstitial nephritis in rats. , 1989, International journal of immunopharmacology.

[11]  R. Renkonen,et al.  Bone marrow transplantation in the rat. I. Histologic correlations and quantitation of cellular infiltrates in acute graft-versus-host disease. , 1984, The American journal of pathology.